Physician profile
Ali Aamar
NPI 1922419209
$1,198.25
in general payments reported to CMS, 2019-2025
11 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $63.50 · 2021: $167 · 2022: $103 · 2023: $223 · 2024: $171 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $538.16 | 2019-2025 | Mavyret, Rinvoq |
| Medtronic, INC. | $174.18 | 2023-2025 | Manoscan, Beacon, Gi Genius |
| Janssen Biotech, INC. | $138.62 | 2023 | Stelara |
| Olympus America INC. | $87.95 | 2021-2025 | Single Use Repositionable Clip, Evis X1 Video System Center |
| Daiichi Sankyo INC. | $82.34 | 2019-2020 | |
| Steris Corporation | $45.56 | 2020 | |
| Cook Medical LLC | $34.11 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $27.84 | 2024 | Iqirvo |
| W. L. Gore & Associates, INC. | $25.16 | 2021 | |
| Boston Scientific Corporation | $22.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.78 | 2024 | Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Aamar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.